Professional Documents
Culture Documents
MULTIPLE CHOICE
1. The study of ethical issues resulting from technologic and scientific advances is called _____.
a. Bioethics c. Medical technology
b. Eugenics d. Scientific method
ANS: A PTS: 1
2. The effort to improve the human species through control of hereditary factors is called _____.
a. Eugenics c. Genetics
b. Euthanasia d. Surrogacy
ANS: A PTS: 1
8. Barriers that exist to providing appropriate treatment to HIV-infected patients include all of the
following with the exception of _____.
a. Confidentiality of the patient’s HIV status
b. Inability to separate suffering from behaviors
c. Risk of contracting the disease from others
d. Universal precautions implemented in facilities
ANS: D PTS: 1
10. Which organization is charged with coordinating the procurement and allocation of human organs and
tissues from donors to recipients
a. UHDDS c. UNITED WAY
b. UNICEF d. UNOS
ANS: D PTS: 1
15. Under GINA, it is permissible for the health information manager to _____.
a. Allow genetic information to be used as a qualification for medical insurance
b. Prohibit the release of genetic information to other health care providers
c. Refuse the release of genetic information for insurance or employment qualifications
d. Release genetic information as a part of an employment physical examination
ANS: C PTS: 1
16. Stem cells are special kinds of cells that are not committed to conducting a specific function, and they
have the capability to renew themselves and _____.
a. Differentiate into specialized cells
b. Harvesting is obtained just from embryos
c. Replace tissues of similar types alone
d. Specifically conducting only certain functions
ANS: A PTS: 1
18. The difference between a living will and a durable power of attorney for healthcare is that a _____.
a. Durable power of attorney designates specific treatments that should be held or withheld
in the event she becomes incapacitated
b. Durable power of attorney and living will are both executed by the family after the patient
becomes incapacitated, determining the surrogate decision maker
c. Living will designates treatment, while a durable power of attorney designates a surrogate
decision maker
d. Living will is executed while the patient is competent and designates a person who makes
decisions in the event he is incapacitated
ANS: C PTS: 1
19. The question of whether to withdraw life support may become more complex when dealing with
_____.
a. Anyone who has a living will
b. Guardians of children
c. Individuals with DNR orders
d. Patients who are incompetent
ANS: D PTS: 1
20. A child with a ruptured spleen from a bicycle accident is quickly deteriorating. His mother, a
Jehovah’s witness, refuses to allow a blood transfusion needed to save his life. What is the
appropriate way to proceed?
a. Proceed without the mother’s consent in c. Request the hospital administration obtain
the best interest of the child an emergency court injunction
b. Refer to the hospital ethics committee d. Honor the mother’s wishes
ANS: C PTS: 1
21. An elderly woman designated a durable power of attorney while still competent. She is now in a
coma and on a ventilator following surgery. The designee feels she is suffering and wishes to withdraw
life support. Other family members disagree and wish to have life support continued. The other family
members also indicate that the designee is beneficiary to half of the patient’s estate and is having
financial problems. What action should be taken?
a. Follow the instructions of the designee because the durable power of attorney for
healthcare is a legal document
b. Instruct the family members that they have to sort it out themselves because the hospital
cannot be involved in any action
c. Permit all parties involved to request that the attending physician order a consultation with
a medical specialist
d. Seek consultation with the local district attorney regarding this conflict of interest so as to
resolve it appropriately
ANS: A PTS: 1
22. Ethical questions involved in or occurring during the period closely surrounding birth are
known as _____ ethics.
a. Eugenics c. Prenatal
b. Genetics d. Perinatal
ANS: D PTS: 1
26. The use of the patient’s own body part for tissue transplant is called _____.
a. Allograft c. Heterograft
b. Autograft d. Xenograft
ANS: B PTS: 1
27. The use of an organ or body part from another human (donor) is called an _____.
a. Allograft c. Heterograft
b. Autograft d. Xenograft
ANS: A PTS: 1
28. The use of animal tissue for organ transplants is called a(n) _____.
a. Allograft c. Heterograft
b. Autograft d. Xylograft
ANS: C PTS: 1
30. In 2008, the U.S. Congress passed _____ legislation that protects the confidentiality of genetic
information?
a. ARRA c. GINA
b. EMTALA d. PSDA
ANS: C PTS: 1
32. Euthanasia is the act or practice of causing death painlessly, with the aim to end suffering. Which act
is associated with passive euthanasia?
a. DNR order c. Withdrawing treatment
b. Initiating the dying process d. Withholding treatment
ANS: A PTS: 1